Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

NCT02679170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Clínico Univ. de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Complejo Hospitalario de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Marqués de Valdecilla Santander, Cantabria, Spain
View all 32 locations
View Trial Details
Completed

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

NCT05068427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Southern Medical University Affiliated Nanfang Hospital Guangzhou, Guangdong, China
  • Guangxi Medical University Affiliated Tumor Hospital Nanning, Guangxi, China
View Trial Details
Completed

A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer

NCT01357395

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • James Graham Brown Cancer Center, University of Louisville Louisville, Kentucky, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

NCT01712217

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic-Scottsdale Scottsdale, Arizona, United States
  • University of California, San Diego Medical Center La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 65 locations
View Trial Details
Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details

Related conditions